Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Chronic Nausea in Advanced Cancer
NCT03137121Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vomiting comparing Olanzapine with Placebo (2 arms). Primary endpoint: Mean Nausea Scores at 7 days. Started Jul 2017; status: completed.
02
Drugs
olanzapine
03
Conditions
Vomiting
Beyond the preview
Go deeper on NCT03137121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137121.